Ozempic tablets contain semaglutide, a GLP-1 receptor agonist indicated for the treatment of adults with type 2 diabetes. The medication helps improve glycemic control by enhancing glucose-dependent insulin secretion, reducing glucagon release, and slowing gastric emptying.

Treatment with semaglutide should be initiated and monitored by a qualified healthcare professional. Patients should follow the prescribed dosing schedule and continue recommended lifestyle measures, including a balanced diet and regular physical activity.

Like all prescription medicines, Ozempic may not be suitable for everyone. A healthcare provider should assess individual medical history, potential side effects, and possible drug interactions before treatment begins.